17July2018

A Newspaper for the health conscious

AVONIC LIFE SCIENCES
Pinorc Life Science

Suresh Prabhu speaking at OPPI annual summit
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

India to push pharma exports to China, other countries: Prabhu

 BS RAWAT
NEW DELHI: India is committed to promoting pharmaceutical exports to China, and other untapped markets, India’s Commerce & Industry Ministry Suresh Prabhu said in New Delhi on July 13, 2018.

1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

China initiates easier import of Indian anti-cancer drugs

 Sonali Thakur
China has said it has initiated specific measures for the import of Indian pharmaceuticals, especially anti-cancer drugs, to provide them “greater access” to the Chinese market, days after a Chinese movie on a leukemia patient highlighted the need for paving the way for import of cheap Indian medicines.

NPPA fixes ceiling prices
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

NPPA fixes ceiling prices of 58 drug formulations

 Rohit Shishodia
India's National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of fifty eight drug formulations used in treatment of various ailments such as cardiovascular diseases, vaginal yeast infections, bacterial infections, high blood pressure, rheumatoid Arthritis, systemic lupus erythematosus and malaria.

Fortis Chairman Ravi Rajagopal
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

IHH Healthcare bags Fortis, to purchase shares at premium

 Sonali Thakur
After months of searching for an investor, Fortis Healthcare Ltd said on Friday that it has accepted an investment offer from Malaysia’s IHH Healthcare, capping a months-long bidding war for control of the firm that drew interest from domestic and international suitors.

Avirup Bose, Associate Professor, Jindal Global Law School
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

Rationalizing margins on medical equipment may cut MRP by 73%

 BS RAWAT
NEW DELHI: Public health experts and industry insiders say that rationalization of trade margins on medical devices will lead to a major drop in their MRP by around 73%. Experts have warned that if India isn’t cautious in the method of calculating trade margin, it may face implications on its exports of medical devices.

Prashant Surana, MD, Boiron India
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

Boiron launches standardized homeopathic medicines in India

BS RAWAT
NEW DELHI: Boiron India, a subsidiary of Boiron France, has said that it has launched pre-medicated standardized homeopathic medicines for the first time in the Indian market.

GLS Pharma

Cubit Pharma